OnKure Therapeutics 13G Filing
OnKure Therapeutics, Inc. subject of Schedule 13G filing, indicating a significant change in ownership. The filing was made on May 27, 2026.
Filed: 2026-05-27 AccNo: 0000921895-26-001486 Size: 39 KB
OnKure Therapeutics, Inc. subject of Schedule 13G filing, indicating a significant change in ownership. The filing was made on May 27, 2026.
Filed: 2026-05-27 AccNo: 0000921895-26-001486 Size: 39 KB